For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $53.57 in the prior trading day, Viking Therapeutics Inc (NASDAQ: VKTX) closed at $49.58, down -7.45%. In other words, the price has decreased by -$7.45 from its previous closing price. On the day, 7.98 million shares were traded. VKTX stock price reached its highest trading level at $53.2 during the session, while it also had its lowest trading level at $48.98.
Ratios:
Our goal is to gain a better understanding of VKTX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 36.47 and its Current Ratio is at 36.47. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on November 04, 2024, Reiterated its Buy rating but revised its target price to $102 from $90 previously.
On September 11, 2024, JP Morgan started tracking the stock assigning a Overweight rating and target price of $80.
On June 27, 2024, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $105.Morgan Stanley initiated its Overweight rating on June 27, 2024, with a $105 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 08 ’24 when MACARTNEY LAWSON sold 2,000 shares for $68.67 per share. The transaction valued at 137,333 led to the insider holds 47,965 shares of the business.
LAWSON MACARTNEY bought 2,000 shares of VKTX for $137,333 on Nov 08 ’24. On Oct 28 ’24, another insider, ZANTE GREG, who serves as the Chief Financial Officer of the company, sold 131,687 shares for $76.61 each. As a result, the insider received 10,089,164 and left with 149,366 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VKTX now has a Market Capitalization of 5524997120 and an Enterprise Value of 4595810816.
Stock Price History:
Over the past 52 weeks, VKTX has reached a high of $99.41, while it has fallen to a 52-week low of $10.34. The 50-Day Moving Average of the stock is -23.25%, while the 200-Day Moving Average is calculated to be -19.70%.
Shares Statistics:
The stock has traded on average 4.10M shares per day over the past 3-months and 8364250 shares per day over the last 10 days, according to various share statistics. A total of 111.44M shares are outstanding, with a floating share count of 107.95M. Insiders hold about 3.12% of the company’s shares, while institutions hold 73.84% stake in the company. Shares short for VKTX as of 1730332800 were 13280561 with a Short Ratio of 3.24, compared to 1727654400 on 14477819. Therefore, it implies a Short% of Shares Outstanding of 13280561 and a Short% of Float of 16.009999999999998.
